← Back to Clinical Trials
Recruiting NCT07343804

NCT07343804 THE EFFECT OF ENDODONTIC TREATMENT ON CARDIOVASCULAR RISK BIOMARKERS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07343804
Status Recruiting
Phase
Sponsor Postgraduate Institute of Dental Sciences Rohtak
Condition Cardiovascular Disease Risk Factor
Study Type INTERVENTIONAL
Enrollment 80 participants
Start Date 2025-11-01
Primary Completion 2026-02

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
root canal treatment and intracanal medicament

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 80 participants in total. It began in 2025-11-01 with a primary completion date of 2026-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Study subjects were obtained from the pool of OPD patients in the Department of Conservative Dentistry and Endodontics, PGIDS, Rohtak, and the Department of Cardiology, PGIMS, Rohtak. Baseline clinical, radiographic, and laboratory parameters (hsCRP and IL-6) were recorded. Patients were then randomly allocated to one of the two groups. In the test group, single-sitting root canal treatment was performed immediately, while in the control group, delayed endodontic intervention (after 3 months) was performed after three months. Clinical and laboratory parameters were again assessed at the end of 3 months in both groups. hsCRP and IL-6 indices were again done in the delayed treatment group after 3 months of root canal treatment.

Eligibility Criteria

Inclusion Criteria: 1. Individuals 30 years of age and older, with a diagnosis of stable coronary artery disease (CAD) and chronic apical periodontitis. 2. All patients had to present with CAD defined by the Brazilian Society of Cardiology (Xavier et al., 2013) as the documented occurrence of one or more of the following events 6 months before entering the study: history of myocardial infarction, stable angina or ischaemia in non-invasive tests; surgical or percutaneous myocardial revascularization and lesion size of greater than 50% in at least one major coronary artery, as assessed by angiography; presence of angina and positive results of non-invasive testing of ischaemia. 3. Presence of apical periodontitis defined by the presence of at least 1 radiographic radiolucency ( ≥ 3mm) in teeth as assessed both clinically and radiographically ,with periapical index (PAI) scores ≥3 in a single permanent tooth and pulp necrosis verified by cold and electric pulp test. \- Exclusion Criteria: 1. Chronic conditions associated with periodontitis or with changes in systemic inflammation (e.g. diabetes mellitus, rheumatoid arthritis, rheumatic fever, malignancy, respiratory diseases, renal diseases). 2. Presence of localized or diffuse periodontal disease. 3. Acute symptomatic patients 4. Presence of CV risk factor - history of smoking 5. Acute conditions known to affect systemic inflammatory markers (orthopaedic trauma, surgery ,viral infections) 6. Medications (during last 3 months) known to affect systemic inflammatory markers (systemic steroids,immunosuppressants, hormone replacement therapy, contraceptives and systemic antibiotics 7. Obesity (body mass index \[BMI\]≥30 kg/m2 8. Pregnancy \& Lactation.37

Contact & Investigator

Central Contact

Nishant Chauhan, MDS

✉ catchnishu619@gmail.com

📞 +919991772647

Frequently Asked Questions

Who can join the NCT07343804 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, studying Cardiovascular Disease Risk Factor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07343804 currently recruiting?

Yes, NCT07343804 is actively recruiting participants. Contact the research team at catchnishu619@gmail.com for enrollment information.

Where is the NCT07343804 trial being conducted?

This trial is being conducted at Rohtak, India.

Who is sponsoring the NCT07343804 clinical trial?

NCT07343804 is sponsored by Postgraduate Institute of Dental Sciences Rohtak. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology